BNC Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,058
Closed -$257K 117
2025
Q4
$257K Hold
5,058
0.07% 87
2025
Q3
$281K Sell
5,058
-1,748
-26% -$102K 0.07% 81
2025
Q2
$470K Hold
6,806
0.14% 63
2025
Q1
$473K Hold
6,806
0.17% 66
2024
Q4
$585K Sell
6,806
-149
-2% -$16.1K 0.19% 64
2024
Q3
$828K Hold
6,955
0.31% 53
2024
Q2
$993K Buy
6,955
+37
+0.5% +$4.9K 0.37% 52
2024
Q1
$888K Hold
6,918
0.38% 51
2023
Q4
$716K Hold
6,918
0.34% 58
2023
Q3
$629K Hold
6,918
0.34% 61
2023
Q2
$560K Hold
6,918
0.3% 63
2023
Q1
$550K Hold
6,918
0.31% 65
2022
Q4
$468K Hold
6,918
0.28% 70
2022
Q3
$345K Hold
6,918
0.21% 80
2022
Q2
$385K Hold
6,918
0.2% 82
2022
Q1
$384K Buy
6,918
+108
+2% +$5.54K 0.19% 79
2021
Q4
$381K Hold
6,810
0.18% 79
2021
Q3
$327K Hold
6,810
0.19% 70
2021
Q2
$285K Hold
6,810
0.17% 72
2021
Q1
$230K Hold
6,810
0.16% 75
2020
Q4
$238K Hold
6,810
0.15% 84
2020
Q3
$236K Buy
+6,810
New +$227K 0.17% 75

Other funds holding NVO

BNC Wealth Management's NVO Position: Q1 2026 in Review

BNC Wealth Management sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 5,058 shares — an estimated $257K sold.

BNC Wealth Management first reported a position in NVO in Q3 2020 and held it in 22 quarters. The position peaked at $993K in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • BNC Wealth Management reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • BNC Wealth Management sold 5,058 Novo Nordisk shares in Q1 2026, an estimated $257K.
  • BNC Wealth Management first reported a position in Novo Nordisk in Q3 2020 and held it in 22 quarters.
  • BNC Wealth Management's Novo Nordisk position peaked at $993K in Q2 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on BNC Wealth Management's 13F filing for Q1 2026, filed 13 Apr 2026.